{
    "nctId": "NCT00309478",
    "briefTitle": "Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients",
    "officialTitle": "A Randomized Phase III Study Comparing Cyclophosphamide + Methotrexate + Fluorouracil vs. Goserelin + Tamoxifen in Premenopausal, Hormone Receptor-positive, Lymph Node-positive or -Negative Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Early-stage Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 1099,
    "primaryOutcomeMeasure": "Disease-free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Premenopausal patients with histologically verified, lymph node-negative (pT1c-pT3) or lymph node-positive (pT1a-pT3) breast cancer\n* Hormone receptor-positive status\n* More than 6 histologically examined lymph nodes\n* Laboratory parameters\n\n  1. hematopoiesis: \\> 3500/\u00b5l leukocytes, \\> 100,000/\u00b5l thrombocytes\n  2. renal function: creatinin \\< 1.5mg %\n  3. hepatic function: GOT \\</= 2.5 x UNL\n  4. bilirubin: \\< 1.5mg %\n  5. metabolic parameters: Na, Ca, K in normal range, normal level of blood sugar\n  6. blood coagulation: PZ \\> 60%\n* Concluded healing process following surgery\n* \\</= 4 weeks interval since surgery\n* Informed consent\n\nExclusion Criteria:\n\n* T4 carcinoma; inflammatory breast cancer, carcinoma in situ\n* Simultaneous or sequential bilateral breast cancer\n* Preoperative tumor-reducing radiotherapy or preoperative tumor-specific medical treatment\n* Male patients\n* Pregnancy or lactation\n* Lacking compliance or understanding of the disease\n* General contraindication against cytostatic treatment\n* Serious concomitant disease preventing implementation of adjuvant therapy or regular follow-up\n* Second carcinoma or status post second carcinoma (except for curatively treated squamous cell carcinoma of the skin or cervical carcinoma in situ)",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}